Unknown PHASE4 INTERVENTIONAL 2-arm NCT01848795

EndoBarrier Versus Intragastric Balloon in Obese Diabetic Patients

Study of Metabolic Effects of EndoBarrier Versus Intragastric Balloon in Obese Patients With Type 2 Diabetes.

Sponsor: The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

Interventions Easy life balloon EndoBarrier Gastrointestinal Liner

Updated 6 times since 2017 Last updated: Mar 23, 2015 Started: May 31, 2013 Primary completion: May 31, 2019 Completion: May 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Obesity and Type 2 Diabetes and is currently ongoing. The Mediterranean Institute for Transplantation and Advanced Specialized Therapies leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Jun 2019 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

Data source: The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Palermo, Italy